Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 November 2022 | Story Jóhann Thormählen | Photo Jóhann Thormählen
Mating Monokoane Louzanne Coetzee Claus Kempen
Louzanne Coetzee, Claus Kempen – who both run for the Kovsie Athletics club – and Mating Monokoane, the University of the Free State (UFS) women’s soccer captain, are joining hands by starting the Louzanne Coetzee Foundation. Here, from the left, are Monokoane, Coetzee, and Kempen at Pellies Park on the UFS Bloemfontein Campus.

Leaving a legacy. Although she is still in the prime of her career, this has motivated Louzanne Coetzee to start a foundation to benefit others.

The sports star, who won silver (1 500 m; T11) and bronze (marathon; T12) medals at the Paralympics in Tokyo in 2021, wants to empower and support para-athletes. And she is joining hands with two fellow Kovsies to do it.

They will invest their time and talents towards the Louzanne Coetzee Foundation, a result of an idea that started while the 29-year-old Coetzee was competing at the Paralympic Games.

The University of the Free State (UFS) Residence Head of Akasia started the foundation in partnership with Claus Kempen, her guide, and Mating Monokoane, the UFS women’s soccer captain.

“I realised there was a gap in development, especially for para-athletes,” she says.

“You get to a certain level, and in South Africa there is uncertainty with regard to funding and educating athletes.”

 

Identifying needs

According to Kempen, the foundation will start by generating funds to assist others. Help can be provided by educating, informing or “physically giving financial aid to someone in need, whether it is a wheelchair, entering for a competition, or a bursary”.

Coetzee serves in many leadership roles, such as the South African Sports Confederation and Olympic Committee (SASCOC) Athletes Commission and says she will make use of these.

“I am involved in the South African Sports Association for the Physically Disabled, and that gives me a good platform to see where help is needed.

“And with Mating involved in the UFS, it gives us good insights into where the needs are.”

Coetzee will also work with organisations such as the Free State Sport Association for the Physically Disabled and Visually Impaired. “I am also going to start getting more involved with KovsieSport. It is very exciting.”

 

Guiding and following

Coetzee and Kempen have been talking about a foundation for some time and she wanted to include Monokoane, the 2022 Prime of Akasia.

They have been working together for the past three years. Coetzee admires her passion, ethics, and “knows she also has a heart for leaving a legacy”.

And it is fitting that their residence motto is: ‘Live, love, learn and leave a legacy’.

Kempen says it is a privilege to be involved.

“Normally my role is to guide Louzanne, but in this instance I am following, and she is taking me on a journey to explore what we can do to empower other individuals and groups.”

He congratulated the UFS on a successful leadership pathway.

“It is something we like to talk about, namely developing students into leaders.”

“Louzanne took the opportunity with Mating, and they went from a student and employee relationship to partners.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept